Skip to main content
. 2020 Nov 11;20:412. doi: 10.1186/s12883-020-01991-y

Table 3.

Angiographic And Clinical Outcomes Of SAC And NSC N(%)

SAC(n = 101) NSC(n = 98) P value
Total procedure-related complication 32 (31.7) 23 (23.5) 0.195a
Ischemic 22 (21.8) 8 (8.2) 0.007a
Intraoperative thrombosis 16 (15.8) 5 (5.1) 0.014a
Postoperative thrombosis 6 (5.9) 3 (3.1) 0.328a
Hemorrhagic 15 (14.8) 17 (17.3) 0.632a
Postoperative hemorrhage 3 (3.0) 0 (0) 0.246b
Intraoperative rupture 12 (11.9) 17 (17.3) 0.275a
Aneurysm rebleeding 6 (5.9) 1 (1.0) 0.119b
Procedure-related motality 7 (6.9) 2 (2.0) 0.170b
Raymond class
 II 63 (62.4) 61 (62.2) 0.985a
 III 38 (37.6) 37 (37.8)
mRS score at charge
 0–2 score 77/94 (81.9) 87/96 (90.6) 0.081a
 3–5 score 17/94 (19.1) 9/96 (9.4)
mRS score in 6-month FU
 0–2 score 76/90 (84.4) 80/89 (89.9) 0.277a
 3–5 score 14/90 (15.6) 9/89 (10.1)
 Complete occlusion in 6-month FU 59/90 (65.6) 43/89 (48.3) 0.020a
 Improved in 6-month FU 8/90 (8.9) 11/89 (12.4) 0.451a
 Stable in 6-month FU 10/90 (11.1) 10/89 (11.2) 0.979a
 Recurrence in 6-month FU 14/90 (15.6) 25/89 (28.1) 0.042a

Data are presented as number (%) or mean ± SD unless otherwise indicated

SAC stent-assisted coil embolization, NSC no-stent coil embolization, ACA anterior cerebral artery, AComA anterior communicating artery, ICA internal carotid artery, MCA middle cerebral artery, PC posterior circulation, PComA posterior communicating artery

a Calculated using chi-square test

b Calculated using Fisher’s exact test

‡ Statistically significant at p ≤ 0.05